Guyana Government Pursues Lenacapavir to Combat HIV
The Government of Guyana is actively working to acquire Lenacapavir, a groundbreaking medication that allows for HIV prevention through just two injections a year. Produced by the U.S. company Gilead, Lenacapavir is currently priced at US$28,000 annually for HIV treatment in the United States. However, it is expected to be available at a significantly reduced […]
![]()




